Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression

Lu,Xiaodong; Chen,Lufang; Chen,Yuanyuan; Shao,Qixiang; Qin,Wenxin

doi:10.3892/etm.2015.2758

Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression

Authors:
- Xiaodong Lu
- Lufang Chen
- Yuanyuan Chen
- Qixiang Shao
- Wenxin Qin
View Affiliations

Affiliations: School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai 200032, P.R. China
Published online on: September 22, 2015 https://doi.org/10.3892/etm.2015.2758
Pages: 1829-1834

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The vacuolar H+-ATPase (V-ATPase) is commonly highly activated in cancer cells and is a potential target of anti‑cancer therapy. Bafilomycin A1 is a specific inhibitor of the c subunit of V‑ATPase. In the present study, the effects of bafilomycin A1 on the BEL‑7402 hepatocellular carcinoma and HO‑8910 ovarian cancer cell lines were respectively studied. In addition, the bafilomycin A1‑induced alterations in the mRNAs and microRNAs (miRNAs) in the cells were detected using microarray methods. The results demonstrated that the growth of the two cell lines was retarded and the metastatic potential was inhibited by bafilomycin A1. Transmission electron microscopy and assays of capsase‑3 and ‑9 suggested that bafilomycin A1 induced apoptosis. Gene Ontology analysis of the microarrays of mRNA‑miRNA integrity showed altered pathways following bafilomycin A1 treatment, including pathways regulating glucose or lipid metabolism, DNA repair or duplication and lysosomes. Quantitative polymerase chain reaction analysis confirmed that miR‑923, miR‑1246, miR‑149*, miR‑638 and miR‑210 were upregulated and miR‑99a, miR‑181a‑2* and miR‑339‑5p were downregulated following bafilomycin A1 treatment. The overlapped altered miRs may be effective targets for the two types of solid tumor, and may have potential for application to the treatment of other types of solid tumor.

View Figures

View References

1	Nishi T and Forgac M: The vacuolar (H⁺)-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 3:94–103. 2002. View Article : Google Scholar : PubMed/NCBI
2	Marshansky V, Rubinstein JL and Grüber G: Eukaryotic V-ATPase: Novel structural findings and functional insights. Biochimica Biophy Acta. 1837:857–879. 2014. View Article : Google Scholar
3	Breton S and Brown D: Regulation of luminal acidification by the V-ATPase. Physiology (Bethesda). 28:318–329. 2013.PubMed/NCBI
4	Sun-Wada GH and Wada Y: Vacuolar-type proton pump ATPases: Acidification and pathological relationships. Histol Histopathol. 28:805–815. 2013.PubMed/NCBI
5	Barar J and Omidi Y: Dysregulated pH in tumor microenvironment checkmates cancer therapy. BioImpacts. 3:149–162. 2013.PubMed/NCBI
6	Chung C, Mader CC, Schmitz JC, Atladottir J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE and Gorelick F: The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest. 91:732–743. 2011. View Article : Google Scholar : PubMed/NCBI
7	Sennoune SR and Martinez-Zaguilan R: Vacuolar H(+)-ATPase signaling pathway in cancer. Curr Protein Pept Sci. 13:152–163. 2012. View Article : Google Scholar : PubMed/NCBI
8	Fogarty FM, O'Keeffe J, Zhadanov A, Papkovsky D, Ayllon V and O'Connor R: HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H(+) ATPase. Oncogene. 33:4653–4663. 2014. View Article : Google Scholar : PubMed/NCBI
9	Nakashima S, Hiraku Y, Tada-Oikawa S, Hishita T, Gabazza EC, Tamaki S, Imoto I, Adachi Y and Kawanishi S: Vacuolar H⁺-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem. 134:359–364. 2003. View Article : Google Scholar : PubMed/NCBI
10	Yan Y, Denef N and Schüpbach T: The vacuolar proton pump, V-ATPase, is required for notch signaling and endosomal trafficking in drosophila. Dev Cell. 17:387–402. 2009. View Article : Google Scholar : PubMed/NCBI
11	Marshansky V and Futai M: The V-type H⁺-ATPase in vesicular trafficking: Targeting, regulation and function. Curr Opin Cell Biol. 20:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
12	Lee GH, Kim DS, Kim HT, Lee JW, Chung CH, Ahn T, Lim JM, Kim IK, Chae HJ and Kim HR: Enhanced lysosomal activity is involved in Bax inhibitor-1-induced regulation of the endoplasmic reticulum (ER) stress response and cell death against ER stress: Involvement of vacuolar H⁺-ATPase (V-ATPase). J Biol Chem. 286:24743–24753. 2011. View Article : Google Scholar : PubMed/NCBI
13	Avnet S, Di Pompo G, Lemma S, Salerno M, Perut F, Bonuccelli G, Granchi D, Zini N and Baldini N: V-ATPase is a candidate therapeutic target for Ewing sarcoma. Biochim Biophys Acta. 1832:1105–1116. 2013. View Article : Google Scholar : PubMed/NCBI
14	Hernandez A, Serrano-Bueno G, Perez-Castineira JR and Serrano A: Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer. Curr Pharm Des. 18:1383–1394. 2012. View Article : Google Scholar : PubMed/NCBI
15	Graham RM, Thompson JW and Webster KA: Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis. Oncotarget. 5:1162–1173. 2014. View Article : Google Scholar : PubMed/NCBI
16	Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F, et al: Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Nat Cancer Inst. 96:1702–1713. 2004. View Article : Google Scholar : PubMed/NCBI
17	Morimura T, Fujita K, Akita M, Nagashima M and Satomi A: The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma. Pediat Surg Int. 24:1087–1094. 2008. View Article : Google Scholar
18	Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477. 2013. View Article : Google Scholar : PubMed/NCBI
19	Wang Y and Taniguchi T: MicroRNAs and DNA damage response: Implications for cancer therapy. Cell Cycle. 12:32–42. 2013. View Article : Google Scholar : PubMed/NCBI
20	von Schwarzenberg K, Wiedmann RM, Oak P, Schulz S, Zischka H, Wanner G, Efferth T, Trauner D and Vollmar AM: Mode of cell death induction by pharmacological vacuolar H⁺-ATPase (V-ATPase) inhibition. J Biol Chem. 288:1385–1396. 2013. View Article : Google Scholar : PubMed/NCBI
21	Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M, Nagakawa T, Miwa K, Kurashima K, Numata M, et al: Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol. 185:324–330. 1998. View Article : Google Scholar : PubMed/NCBI
22	Hendrix A, Sormunen R, Westbroek W, Lambein K, Denys H, Sys G, Braems G, Van den Broecke R, Cocquyt V, Gespach C, et al: Vacuolar H⁺ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer. 133:843–854. 2013. View Article : Google Scholar : PubMed/NCBI
23	Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou CX, Zhang C, Zhang Z and Li X: The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer. Diagn Pathol. 8:1452013. View Article : Google Scholar : PubMed/NCBI
24	Dechant R, Binda M, Lee SS, Pelet S, Winderickx J and Peter M: Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J. 29:2515–2526. 2010. View Article : Google Scholar : PubMed/NCBI
25	Valapala M, Wilson C, Hose S, Bhutto IA, Grebe R, Dong A, Greenbaum S, Gu L, Sengupta S, Cano M, et al: Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy. 10:480–496. 2014. View Article : Google Scholar : PubMed/NCBI
26	Zhang CS, Jiang B, Li M, Zhu M, Peng Y, Zhang YL, Wu YQ, Li TY, Liang Y, Lu Z, et al: The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20:526–540. 2014. View Article : Google Scholar : PubMed/NCBI
27	Cao X, Yang Q, Qin J, Zhao S, Li X, Fan J, Chen W, Zhou Y, Mao H and Yu X: V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells. Am J Physiol Renal Physiol. 302:F1121–F1132. 2012. View Article : Google Scholar : PubMed/NCBI
28	Jung JY and Robinson CM: Interleukin-27 inhibits phagosomal acidification by blocking vacuolar ATPases. Cytokine. 62:202–205. 2013. View Article : Google Scholar : PubMed/NCBI